Free Trial

TherapeuticsMD (TXMD) Institutional Ownership

TherapeuticsMD logo
$2.12 0.00 (0.00%)
As of 05/22/2026 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for TherapeuticsMD (NASDAQ:TXMD)

Current
Institutional Ownership
Percentage
30.74%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$231.17K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$27.71K
Get TXMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling TherapeuticsMD stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

TXMD Institutional Buying and Selling by Quarter

TherapeuticsMD Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026 Renaissance Technologies LLC146,200$295K0.0%+51.5%1.264%
2/18/2026 Bridgeway Capital Management LLC17,000$28K0.0%-50.0%0.147%
2/12/2026 Renaissance Technologies LLC96,500$157K0.0%+171.8%0.834%
2/5/2026 Tejara Capital Ltd350,852$572K0.1%+1.9%3.032%
11/17/2025 Citadel Advisors LLC34,273$36K0.0%+125.5%0.296%
5/13/2025Tejara Capital Ltd344,595$319K0.1%-12.7%2.977%
8/16/2024Clearline Capital LP636,622$1.03M0.0%+18.9%5.521%
5/15/2024Gabelli Funds LLC12,000$27K0.0%-58.6%0.104%
5/1/2024Prosperity Consulting Group LLC24,500$56K0.0%N/A0.212%
2/14/2024ADAR1 Capital Management LLC272,160$612K0.2%N/A2.572%
8/11/2023Tejara Capital Ltd369,594$1.52M0.7%+3.9%3.645%
7/11/2023Sanders Morris Harris LLC25,000$103K0.0%-25.5%0.247%
5/15/2023Rubric Capital Management LP1,192,191$4.47M0.1%-32.2%11.763%
5/12/2023Tejara Capital Ltd355,679$1.33M0.7%+12.1%3.509%
4/7/2023Sanders Morris Harris LLC33,577$126K0.0%-16.9%0.356%
11/14/2022Gabelli Funds LLC31,000$206K0.0%-8.8%0.329%
11/14/2022Rubric Capital Management LP1,156,953$7.68M0.4%+46.1%12.275%
11/10/2022Gabelli Funds LLC31,000$206K0.0%-8.8%0.329%
10/7/2022Sanders Morris Harris LLC40,393$268K0.1%N/A0.429%
8/16/2022PenderFund Capital Management Ltd.24,410$313K0.1%N/A0.276%
5/12/2022Healthcare of Ontario Pension Plan Trust Fund3,445,600$1.31M0.0%N/A39.746%
5/12/2022Cetera Advisors LLC70,850$27K0.0%-6.6%0.817%
5/11/2022GSA Capital Partners LLP208,503$79K0.0%N/A0.048%
4/29/2022McDonald Partners LLC130,000$49K0.0%N/A0.030%
2/14/2022Point72 Hong Kong Ltd123,517$44K0.0%+236.8%0.029%
2/9/2022Principal Financial Group Inc.116,056$41K0.0%-25.6%0.027%
2/8/2022Raymond James & Associates87,357$31K0.0%-51.6%0.021%
2/8/2022Northern Trust Corp3,680,453$1.31M0.0%-10.3%0.868%


TXMD Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of TherapeuticsMD shares: Clearline Capital LP ($1.03M), Tejara Capital Ltd ($572K), Renaissance Technologies LLC ($295K), and Citadel Advisors LLC ($36K), Bridgeway Capital Management LLC ($28K).Learn more on TherapeuticsMD's institutional investors.

30.74% of TherapeuticsMD's stock is owned by institutional investors. Learn more on TXMD's institutional investor holdings.

The following institutional investors have purchased TherapeuticsMD's stock in the last 24 months: Renaissance Technologies LLC ($110.70K), Clearline Capital LP ($101.28K), Citadel Advisors LLC ($19.07K), and Tejara Capital Ltd ($6.65K).

Institutional investors have bought a total of 136,422 shares in the last 24 months. This purchase volume represents approximately $231.17K in transactions.

The following institutional investors have sold TherapeuticsMD stock in the last 24 months: Bridgeway Capital Management LLC ($17K).

Institutional investors have sold a total of 17,000 shares in the last 24 months. This volume of shares sold represents approximately $27.71K in transactions.



This page (NASDAQ:TXMD) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners